Table 1.

Clinical characteristics of 120 patients enrolled in the study

Clinical characteristics	Total	PET group (N = 60)	TRUS group (N = 60)	P
Age/y	71.1 ± 8.4	71.6 ± 9.1	70.6 ± 7.7	0.5204
Prostate volume/ml PSA(ng/ml)	64.1 ± 33.6 28.2 ± 26.5	62.9 ± 29.1 27.4 ± 28.1	65.4 ± 38.9 28.5 ± 27.9	0.4909 0.9977
PSA Subgroups				0.3678
4~20 ng/ml	71	37	34
20 ~ ng/ml	49	23	26
No. of PCa(%)	45(37.5)	26(43.3)	19(31.6)	0.1869
No. of csPCa(%)	39(32.5)	24(40.0)	15(25.0)	0.0794

PCa, prostate cancer; csPCa, clinically significant prostate cancer